The National Institute for Health and Clinical Excellence (NICE) in the UK, has recommended Novartis' Lucentis (ranibizumab) be approved for use in the National Health Service (NHS) in England and Wales. Ranibizumab is used to treat ...
Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin has signed a co-promotion agreement with Santen Pharmaceutical for Eylea (aflibercept) injection in Japan. Eylea is approved for sale in the US and Australia for the treatment of ...